A Phase 1b/2 Open-Label Study to Evaluate the Safety and Efficacy of Lucitanib in Combination with Nivolumab in Patients with an Advanced Metastatic Solid Tumor
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
